FRT vs TLRY · rev $1.28B vs rev $915.5M
FRT (FRT) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
FRT (FRT) common stock.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported FRT revenue for 2025-12-31 was $1.28B. Net income was $411.1M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. FRT currently screens at market cap $0.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
FRT currently screens at market cap $0. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the FRT and TLRY stock pages for the full models.
Not investment advice.